Abstract
AbstractTo review the anatomic basis of prostate boundary selection on T2-weighted magnetic resonance imaging (MRI). To introduce an alternative 3D ellipsoid measuring technique that maximizes precision, report the intra- and inter-observer reliability, and to advocate it’s use for research involving multiple observers. We demonstrate prostate boundary anatomy using gross pathology and MRI examples. This provides background for selecting key boundary marks when measuring prostate volume. An alternative ellipsoid volume method is then proposed using these boundaries in an attempt to improve inter-observer precision. An IRB approved retrospective study of 140 patients with elevated serum prostate specific antigen levels and/or abnormal digital rectal examinations was done with T2-weighted MRI applying a new (Biproximate) technique. Measurements were made by 2 examiners, correlated with each other for inter-observer precision and correlated with an expert observer for accuracy. Correlation statistics, linear regression analysis, and tests of means were applied using p ≤ 0.05 as the threshold for significance. Inter-observer correlation (precision) was 0.95 between observers. Correlation between these observers and the expert (accuracy) was 0.94 and 0.97 respectively. Intra-observer correlation for the expert was 0.98. Means for inter-rater reliability and accuracy were all the same (p = 0.001). We conclude that using more precise reproducible landmarks with biproximate technique, precision and accuracy of total prostate volume is found to be demonstrated.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Radwan, M. H. et al. Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure. Urology. 69, 1121–1127 (2007).
2. Magheli, A. et al. Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy. J. Urol. 179, 1780–1784 (2008).
3. Garvey, B. et al. Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia. Diagn Interv. Radiol. 20, 229–233 (2014).
4. Wasserman, N. F., Spilseth, B., Golzarian, J. & Metzger, G. J. MRI Lobar classification of benign prostatic hyperplasia: Potential phenotype biomarkers for research on treatment strategies. AJR. 205, 564–571 (2015).
5. Littrup, P. J., Williams, C. R., Egglin, T. K. & Kane, R. A. Determination of prostate volume with transrectal ultrasound for cancer screening. Part II. Accuracy of in vitro and in vivo techniques. Radiology. 179, 49–53 (1991).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献